Product
mRNA-1325
1 clinical trial
1 indication
Indication
Zika virusClinical trial
A Phase 1, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of mRNA 1325 Zika Vaccine in Healthy Adults in a Non-endemic Zika RegionStatus: Completed, Estimated PCD: 2019-07-31